Oncobiologics raises $31m for biosimilars; RaNA, Ra, SutroVax add VC cash
This article was originally published in Scrip
Executive Summary
Smart companies are raising money to advance drug development programs while investors are pouring cash into the biotechnology industry. The latest to raise private capital: Oncobiologics, Ra Pharmaceuticals, RaNA Therapeutics and SutroVax.